Comprehensive Nano - Post Market Clinical Follow-Up Study

NCT03423953 · tracked via the Priya Life Science UK tracker

Sponsor

Zimmer Biomet

Phase

Observational

Started

2013-10-30

Last updated

2026-04-21

Condition(s) studied

OsteoarthritisAvascular NecrosisRheumatoid ArthritisRevisionCorrection of Functional Deformity

Investigational drug(s) / intervention(s)

Comprehensive Nano

Comprehensive Nano: Patients requiring the Comprehensive Nano shoulder system.

Study summary

This data collection project is intended to provide clinical outcomes data to engineering, marketing as well as fulfill the post market surveillance requirements of various regulatory authorities. The study will be a prospective and one-arm.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis. * Rheumatoid arthritis * Revision where other devices or treatments have failed * Correction of functional deformity. * Difficult clinical management problems where other methods of treatment may not be suitable or may be inadequate * Difficult clinical management problems where other methods of treatment may not be suitable or may be inadequate Exclusion Criteria: * Infection * Sepsis * osteomyelitis

Primary outcome measure(s)

Survivorship — 10 years
Kaplan Meier method

Trial sites (5)

Facility	City	Region
Privatklinik Leech	Graz	Styria
Kingston General Hospital	Kingston	Ontario
Chonnam National University Hospital	Gwangju	Gwangju
Samsung Medical Centre	Seoul	Seoul
University of Liverpool	Liverpool	Merseyside

More Zimmer Biomet trials in the UK

Comprehensive Segmental Revision System Active, not recruiting

Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System Active, not recruiting

Zimmer® Natural Nail® (ZNN) Bactiguard Tibia Post-Market Clinical Follow-up Study Recruiting

Clinical Outcomes Study of the Nexel Total Elbow Recruiting

Anatomical Shoulder Domelock System Study Active, not recruiting

Other trials for the same condition

A Study of AZD0120 in Autoimmune Diseases Recruiting

Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System Active, not recruiting

The Medacta International GMK Sphere Post-Marketing Surveillance Study Active, not recruiting

A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR) Active, not recruiting

AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03423953 on ClinicalTrials.gov ↗ ← All trials in the UK